TABLE OF CONTENTS

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY

1.2. MARKET DEFINITION

1.3. OVERVIEW OF GLOBAL POINT-OF-CARE TESTING MARKET

1.4. CURRENCY AND PRICING

1.5. LIMITATION

1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7. SECONDARY SOURC

2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. GROWING GERIATRIC POPULATION

3.1.2. ADVANCEMENT IN TECHNOLOGY

3.1.3. DECENTRALIZED LABORATORY TESTING

3.1.4. INCREASED INCIDENCE OF CHRONIC DISEASES

3.1.5. LABORATORY STAFF SHORTAGES

3.2. RESTRAINTS

3.2.1. UNFAVOURABLE REIMBURSEMENT SCENARIO

3.2.2. ECONOMIC COST

3.3. OPPORTUNITIES

3.3.1. EMERGING MICROFLUIDIC LAB-ON-A-CHIP TECHNOLOGY

3.3.2. EMERGING MARKETS

3.3.3. UNMET MEDICAL NEEDS

3.4. CHALLENGES

3.4.1. LACK OF ACCURACY AND EFFICIENCY

3.4.2. DATA MANAGEMENT AND LACK OF CONNECTIVITY

3.4.3. TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO

6.1. OVERVIEW:

6.1.1. REGULATORY PROCEDURE:

7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO

7.1. OVERVIEW:

8. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE

8.1. OVERVIEW

8.2. CARDIOMETABOLIC MONITORING KITS

8.2.1. CARDIAC MARKERS

8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS

8.2.3. HBA1C TESTING KITS

8.2.4. LIPID TESTING KITS

8.3. INFECTIOUS DISEASE TESTING KITS

8.3.1. INFLUENZA TESTING KITS

8.3.2. HIV TESTING KITS

8.3.3. HEPATITIS TESTING KITS

8.3.4. STD TESTING KITS

8.3.5. TROPICAL DISEASESTESTING KITS

8.3.6. HEALTHCARE ASSOCIATED TESTING KITS

8.3.7. RESPIRATORY INFECTIONS TESTING KITS

8.4. CHOLESTEROL TESTING KITS

8.4.1. PROTHROMBIN TIME TESTING KITS

8.4.2. ACTIVATED CLOTTING TIME TESTING KITS

8.5. BLOOD GLUCOSE TESTING KITS

8.6. PREGNANCY AND FERTILITY TESTING KITS

8.7. TUMOR CANCER MARKERS

8.8. URINALYSIS TESTING KITS

8.9. HEMATOLOGY TESTING KITS

8.10. DRUGS OF ABUSE TESTING KITS

8.11. FECAL OCCULT TESTING KITS

8.12. RAPID COAGULATION TESTING KITS

9. GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW

9.1.1. DIRECT TENDER

9.1.2. RETAIL PHARMACY

10. GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER

10.1. OVERVIEW

10.2. GLOBAL POCT MARKET: HOSPITALS

10.3. GLOBAL POCT MARKET: CLINICS

10.4. GLOBAL POCT MARKET: AMBULATORY CARE

10.5. GLOBAL POCT MARKET: HOME HEALTHCARE

10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES

11. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

11.1. OVERVIEW

11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS

11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS

12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY

12.1. OVERVIEW

12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET

12.2.1. U.S.POINT-OF-CARE TESTING MARKET

12.2.2. CANADA POINT-OF-CARE TESTING MARKET

12.2.3. MEXICO POINT-OF-CARE TESTING MARKET

12.3. EUROPE POINT-OF-CARE TESTING MARKET

12.3.1. GERMANY POINT-OF-CARE TESTING MARKET

12.3.2. FRANCE POINT-OF-CARE TESTING MARKET

12.3.3. U.K. POINT-OF-CARE TESTING MARKET

12.3.4. ITALY POINT-OF-CARE TESTING MARKET

12.3.5. SPAIN POINT-OF-CARE TESTING MARKET

12.3.6. RUSSIA POINT-OF-CARE TESTING MARKET

12.3.7. TURKEY POINT-OF-CARE TESTING MARKET

12.3.8. BELGIUM POINT-OF-CARE TESTING MARKET

12.3.9. NETHERLANDS POINT-OF-CARE TESTING MARKET

12.3.10. SWITZERLAND POINT-OF-CARE TESTING MARKET

12.3.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET

12.4. APAC POINT-OF-CARE TESTING MARKET

12.4.1. JAPAN POINT-OF-CARE TESTING MARKET

12.4.2. CHINA POINT-OF-CARE TESTING MARKET

12.4.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET

12.4.4. INDIA POINT-OF-CARE TESTING MARKET

12.4.5. AUSTRALIA POINT-OF-CARE TESTING MARKET

12.4.6. SINGAPORE POINT-OF-CARE TESTING MARKET

12.4.7. THAILAND POINT-OF-CARE TESTING MARKET

12.4.8. MALAYSIA POINT-OF-CARE TESTING MARKET

12.4.9. INDONESIA POINT-OF-CARE TESTING MARKET

12.4.10. PHILIPPINES POINT-OF-CARE TESTING MARKET

12.4.11. REST OF APAC POINT-OF-CARE TESTING MARKET

12.5. MEA POINT-OF-CARE TESTING MARKET

12.5.1. SOUTH AFRICA POINT-OF-CARE TESTING MARKET

12.5.2. SAUDI ARABIA POINT-OF-CARE TESTING MARKET

12.5.3. UAE POINT-OF-CARE TESTING MARKET

12.5.4. REST OF MEA POINT-OF-CARE TESTING MARKET

12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET

12.6.1. BRAZIL POINT-OF-CARE TESTING MARKET

13. GLOBAL POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE

13.1. COMPANY SHARE ANALYSIS: GLOBAL

13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3. COMPANY SHARE ANALYSIS: EUROPE

13.4. COMPANY SHARE ANALYSIS: APAC

14. COMPANY PROFILES

14.1. JOHNSON AND JOHNSON SERVICES, INC.

14.1.1. COMPANY OVERVIEW

14.1.2. REVENUE ANALYSIS

14.1.3. PRODUCT PORTFOLIO

14.1.4. RECENT DEVELOPMENTS

14.2. BECTON, DICKINSON AND COMPANY

14.2.1. COMPANY OVERVIEW

14.2.2. REVENUE ANALYSIS

14.2.3. PRODUCT PORTFOLIO

14.2.4. RECENT DEVELOPMENTS

14.3. MEDTRONIC

14.3.1. COMPANY OVERVIEW

14.3.2. REVENUE ANALYSIS

14.3.3. PRODUCT PORTFOLIO

14.3.4. RECENT DEVELOPMENTS

14.4. F. HOFFMANN-LA ROCHE LTD

14.4.1. COMPANY OVERVIEW

14.4.2. REVENUE ANALYSIS

14.4.3. PRODUCT PORTFOLIO

14.4.4. RECENT DEVELOPMENTS

14.5. SIEMENS AG

14.5.1. COMPANY OVERVIEW

14.5.2. REVENUE ANALYSIS

14.5.3. PRODUCT PORTFOLIO

14.5.4. RECENT DEVELOPMENTS

14.6. ABBOTT

14.6.1. COMPANY OVERVIEW

14.6.2. REVENUE ANALYSIS

14.6.3. PRODUCT PORTFOLIO

14.6.4. PRODUCT PIPELINE

14.6.5. RECENT DEVELOPMENTS

14.7. DANAHER

14.7.1. COMPANY OVERVIEW

14.7.2. REVENUE ANALYSIS

14.7.3. PRODUCT PORTFOLIO

14.7.4. RECENT DEVELOPMENTS

14.8. WERFENLIFE

14.8.1. COMPANY OVERVIEW

14.8.2. REVENUE ANALYSIS

14.8.3. PRODUCT PORTFOLIO

14.8.4. RECENT DEVELOPMENTS

14.9. HENRY SCHEIN, INC.

14.9.1. COMPANY OVERVIEW

14.9.2. REVENUE ANALYSIS

14.9.3. PRODUCT PORTFOLIO

14.9.4. RECENT DEVELOPMENTS

14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)

14.10.1. COMPANY OVERVIEW

14.10.2. REVENUE ANALYSIS

14.10.3. PRODUCT PORTFOLIO

14.10.4. RECENT DEVELOPMENTS

14.11. SIENCO, INC.

14.11.1. COMPANY OVERVIEW

14.11.2. REVENUE ANALYSIS

14.11.3. PRODUCT PORTFOLIO

14.11.4. RECENT DEVELOPMENTS

14.12. ACON LABORATORIES, INC.

14.12.1. COMPANY OVERVIEW

14.12.2. REVENUE ANALYSIS

14.12.3. PRODUCT PORTFOLIO

14.12.4. RECENT DEVELOPMENTS

14.13. ATIVA MEDICAL CORPORATION

14.13.1. COMPANY OVERVIEW

14.13.2. REVENUE ANALYSIS

14.13.3. PRODUCT PORTFOLIO

14.13.4. RECENT DEVELOPMENTS

14.14. ABAXIS

14.14.1. COMPANY OVERVIEW

14.14.2. REVENUE ANALYSIS

14.14.3. PRODUCT PORTFOLIO

14.14.4. RECENT DEVELOPMENTS

14.15. ARKRAY, INC

14.15.1. COMPANY OVERVIEW

14.15.2. REVENUE ANALYSIS

14.15.3. PRODUCT PORTFOLIO

14.15.4. RECENT DEVELOPMENTS

14.16. AERSCHER DIAGNOSTICS, LLC

14.16.1. COMPANY OVERVIEW

14.16.2. REVENUE ANALYSIS

14.16.3. PRODUCT PORTFOLIO

14.16.4. RECENT DEVELOPMENTS

14.17. ARTRON LABORATORIES, INC.

14.17.1. COMPANY OVERVIEW

14.17.2. REVENUE ANALYSIS

14.17.3. PRODUCT PORTFOLIO

14.17.4. RECENT DEVELOPMENTS

14.18. BIOMERIEUX SA

14.18.1. COMPANY OVERVIEW

14.18.2. REVENUE ANALYSIS

14.18.3. PRODUCT PORTFOLIO

14.18.4. RECENT DEVELOPMENTS

14.19. ENTOPSIS

14.19.1. COMPANY OVERVIEW

14.19.2. REVENUE ANALYSIS

14.19.3. PRODUCT PORTFOLIO

14.19.4. RECENT DEVELOPMENTS

14.20. LIFESIGN, LLC.

14.20.1. COMPANY OVERVIEW

14.20.2. REVENUE ANALYSIS

14.20.3. PRODUCT PORTFOLIO

14.20.4. RECENT DEVELOPMENTS

15. RELATED REPORTS

TABLE LIST

TABLE 1 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES

TABLE 2 GLOBAL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 3 GLOBAL CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 4 GLOBAL INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 5 GLOBAL CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 6 GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)

TABLE 7 DISTRIBUTION CHANNEL, DIRECT TENDER, BY REGION, 2015 – 2024 (USD MILLION)

TABLE 8 DISTRIBUTION CHANNEL, RETAIL PHARMACY, BY REGION, 2015 – 2024 (USD MILLION)

TABLE 9 GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 10 GLOBAL POINT-OF-CARE TESTING MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION)

TABLE 11 GLOBAL POINT-OF-CARE TESTING MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION)

TABLE 12 GLOBAL POINT-OF-CARE TESTING MARKET, AMBULATORY CARE, BY REGION 2015– 2024 (USD MILLION)

TABLE 13 GLOBAL POINT-OF-CARE TESTING MARKET, HOME HEALTHCARE, BY REGION 2015– 2024 (USD MILLION)

TABLE 14 GLOBAL POINT-OF-CARE TESTING MARKET, RESEARCH LABORATORY, BY REGION 2015– 2024 (USD MILLION)

TABLE 15 GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION)

TABLE 16 GLOBAL POINT-OF-CARE TESTING MARKET, PRESCRIPTION BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION)

TABLE 17 GLOBAL POINT-OF-CARE TESTING MARKET, OVER THE COUNTER BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION)

TABLE 18 GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION)

TABLE 19 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)

TABLE 20 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 21 NORTH AMERICA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 22 NORTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)

TABLE 23 NORTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)

TABLE 24 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION)

TABLE 25 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 26 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 27 U.S.POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 28 U.S. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 29 U.S. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 30 U.S. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 31 CANADA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 32 CANADA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 33 CANADA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 34 CANADA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 35 MEXICO POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 36 MEXICO POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 37 MEXICO POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 38 MEXICO POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 39 EUROPE POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)

TABLE 40 EUROPE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 41 EUROPE CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 42 EUROPE INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 43 EUROPE CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 44 EUROPE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION)

TABLE 45 EUROPE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 46 EUROPE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 47 GERMANY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 48 GERMANY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION)

TABLE 49 GERMANY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 50 GERMANY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 51 FRANCE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 52 FRANCE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)

TABLE 53 FRANCE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 54 FRANCE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 55 U.K. POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 56 U.K. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 57 U.K. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 58 U.K. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 59 ITALY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 60 ITALY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 61 ITALY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 62 ITALY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 63 SPAIN POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 64 SPAIN POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 65 SPAIN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 66 SPAIN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 67 RUSSIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 68 RUSSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 69 RUSSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 70 RUSSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 71 TURKEY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 72 TURKEY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 73 TURKEY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 74 TURKEY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 75 BELGIUM POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 76 BELGIUM POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 77 BELGIUM POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 78 BELGIUM POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 79 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 80 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 81 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 82 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 83 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 84 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 85 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 86 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015–2024 (USD MILLION)

TABLE 87 REST OF EUROPE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 88 APAC POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)

TABLE 89 APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 90 APAC CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 91 APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 92 APAC CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 93 APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 94 APAC POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 95 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION)

TABLE 96 JAPAN POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 97 JAPAN POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)

TABLE 98 JAPAN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 99 JAPAN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 100 CHINA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 101 CHINA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)

TABLE 102 CHINA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 103 CHINA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 104 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 105 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 106 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 107 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 108 INDIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 109 INDIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 110 INDIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 111 INDIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION)

TABLE 112 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 113 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 114 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 115 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 116 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 117 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 118 SINGAPORE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 119 SINGAPORE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 120 THAILAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 121 THAILAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 122 THAILAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 123 THAILAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 124 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 125 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 126 MALAYSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 127 MALAYSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 128 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 129 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 130 INDONESIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 131 INDONESIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 132 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 133 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 134 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 135 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 136 REST OF APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 137 MEA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)

TABLE 138 MEA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 139 MEA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 140 MEA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE,2015 – 2024 (USD MILLION)

TABLE 141 MEA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 142 MEA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 143 MEA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 144 MEA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 145 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 146 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 147 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 148 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015–2024 (USD MILLION)

TABLE 149 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 150 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 151 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 152 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 153 UAE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 154 UAE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)

TABLE 155 UAE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 156 UAE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 157 REST OF MEA POINT-OF-CARE TESTING MARKET, BY PRODUCTTYPE, 2015 – 2024 (USD MILLION)

TABLE 158 SOUTH AMERICA: HEALTHCARE SPENDING (USD PER HEAD)

TABLE 159 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY,2015 – 2024 (USD MILLION)

TABLE 160 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

TABLE 161 SOUTH AMERICA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 162 SOUTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)

TABLE 163 SOUTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 164 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 165 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY END-USER, 2015 – 2024 (USD MILLION)

TABLE 166 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 167 BRAZIL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 168 BRAZIL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 169 BRAZIL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 170 BRAZIL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

FIGURES LIST

FIGURE 1 GLOBAL POINT-OF-CARE TESTING MARKET: SEGMENTATION

FIGURE 2 GLOBAL POINT-OF-CARE TESTING MARKET: GEOGRAPHIC SCOPE

FIGURE 3 GLOBAL POINT-OF-CARE TESTING MARKET: DATA TRIANGULATION

FIGURE 4 GLOBAL POINT-OF-CARE TESTING MARKET RESEARCH SNAPSHOT

FIGURE 5 GLOBAL POINT-OF-CARE TESTING MARKET BOTTOM UP APPROACH

FIGURE 6 GLOBAL POINT-OF-CARE TESTING MARKET TOP DOWN APPROACH

FIGURE 7 GLOBAL POINT-OF-CARE TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE POINT-OF-CARE TESTING MARKET

FIGURE 9 GLOBAL POINT-OF-CARE TESTING MARKET: SEGMENTATION

FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR POINT-OF-CARE TESTINGIN 2016 AND APAC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024

FIGURE 11 HIGH PREVALANCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE MARKET FOR POINT-OF-CARE TESTING IN THE FORECAST PERIOD 2017 TO 2024

FIGURE 12 BLOOD GLUCOSE TESTING MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE POINT-OF-CARE TESTING MARKET IN 2017 & 2024

FIGURE 13 NORTH AMERICA IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR POINT-OF-CARE TESTING MANUFACTURERS IN THE FORECAST PERIOD TO 2024

FIGURE 14 GLOBAL POINT-OF-CARE TESTING MARKET: BY TYPE, SNAPSHOT 2016

FIGURE 15 GLOBAL POCT MARKET: CARDIOMETABOLIC MONITORING KITS MARKET: BY REGION

FIGURE 16 GLOBAL POCT MARKET: INFECTIOUS DISEASE TESTING KITS MARKET: BY REGION

FIGURE 17 GLOBAL POCT MARKET: CHOLESTROL TESTING KITS MARKET: BY REGION

FIGURE 18 GLOBAL POCT MARKET: BLOOD GLUCOSE TESTING KITS MARKET: BY REGION

FIGURE 19 GLOBAL POCT MARKET: PREGNANCY AND FERTILITY TESTING KITS MARKET: BY REGION

FIGURE 20 GLOBAL POCT MARKET: TUMOR CANCER MARKERS MARKET: BY REGION

FIGURE 21 GLOBAL POCT MARKET: URINALYSIS TESTING KITS MARKET: BY REGION

FIGURE 22 GLOBAL POCT MARKET: HEMATOLOGY TESTING KITS MARKET: BY REGION

FIGURE 23 GLOBAL POCT MARKET: DRUGS OF ABUSE TESTING KITS MARKET: BY REGION

FIGURE 24 GLOBAL POCT MARKET: FECAL OCCULT TESTING KITS MARKET: BY REGION

FIGURE 25 GLOBAL POCT MARKET: RAPID COAGULATION TESTING KITSMARKET: BY REGION

FIGURE 26 GLOBAL POINT-OF-CARE TESTING MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016

FIGURE 27 GLOBAL POCT MARKET: DIRECT TENDER MARKET: BY REGION

FIGURE 28 RETAIL PHARMACY MARKET: BY REGION

FIGURE 29 GLOBAL POINT-OF-CARE TESTING MARKET DOMINATED BY HOSPITALS SEGMENT

FIGURE 30 GLOBAL POINT-OF-CARE TESTING MARKET:BY END-USER, SNAPSHOT 2016

FIGURE 31 GLOBAL POCT MARKET: HOSPITALS; BY REGION

FIGURE 32 GLOBAL POCT MARKET: CLINICS; BY REGION

FIGURE 33 GLOBAL POCT MARKET: AMBULATORY CARE; B

FIGURE 34 GLOBAL POCT MARKET: HOME HEALTHCARE; BY REGION

FIGURE 35 GLOBAL POCT MARKET: RESEARCH LABORATORY; BY REGION

FIGURE 36 GLOBAL POINT-OF-CARE TESTING MARKET:BY PRESCRIPTION MODE, SNAPSHOT 2016

FIGURE 37 GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS; BY REGION

FIGURE 38 GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS; BY REGION

FIGURE 39 NORTH AMERICA POINT-OF-CARE TESTING MARKET SNAPSHOT (2017)

FIGURE 40 NORTH AMERICA POINT-OF-CARE TESTING MARKET : BY COUNTRY (2017)

FIGURE 41 NORTH AMERICA POINT-OF-CARE TESTING MARKET BY COUNTRY (2016 & 2024)

FIGURE 42 NORTH AMERICA POINT-OF-CARE TESTING MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 43 EUROPEPOINT-OF-CARE TESTING MARKET SNAPSHOT (2017)

FIGURE 44 EUROPEPOINT-OF-CARE TESTING MARKET BY COUNTRY (2017)

FIGURE 45 EUROPE POINT-OF-CARE TESTING MARKET BY COUNTRY (2016 & 2024)

FIGURE 46 EUROPEPOINT-OF-CARE TESTING MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 47 APACPOINT-OF-CARE TESTING MARKET : SNAPSHOT (2017)

FIGURE 48 APACPOINT-OF-CARE TESTING MARKET : BY COUNTRY (2017)

FIGURE 49 APAC POINT-OF-CARE TESTING MARKET :BY PRODUCT TYPE (2016 & 2024)

FIGURE 50 MEA POINT-OF-CARE TESTING MARKET: SNAPSHOT (2017)

FIGURE 51 MEA POINT-OF-CARE TESTING MARKET: BY COUNTRY (2017

FIGURE 52 MEA POINT-OF-CARE TESTING MARKET:BY PRODUCT TYPE (2016 & 2024)

FIGURE 53 SOUTH AMERICAPOINT-OF-CARE TESTING MARKET : SNAPSHOT (2017)

FIGURE 54 SOUTH AMERICAPOINT-OF-CARE TESTING MARKET : BY COUNTRY (2017)

FIGURE 55 SOUTH AMERICA POINT-OF-CARE TESTING MARKET : BY PRODUCT TYPE (2016 & 2024)

FIGURE 56 GLOBAL POINT-OF-CARE TESTING MARKET: COMPANY SHARE 2016 (%)

FIGURE 57 NORTH AMERICA POINT-OF-CARE TESTING MARKET: COMPANY SHARE 2016 (%)

FIGURE 58 EUROPE POINT-OF-CARE TESTING MARKET: COMPANY SHARE 2016 (%)

FIGURE 59 APAC POINT-OF-CARE TESTING MARKET: COMPANY SHARE 2016 (%)